◀ Back to TNF
CEBPA — TNF
Pathways - manually collected, often from reviews:
-
OpenBEL Selventa BEL large corpus:
CEBPA
→
TNF
(decreases, TNF Activity)
Evidence: expression of TNF-a suppresses the transcription factor C/EBP-a, which in turn activates the GLUT4 gene. TNF-a also suppresses the expression of PPARG. Gene ablation of TNF-a or the TNF-a receptor leads to improved insulin sensitivity in rodents.
-
OpenBEL Selventa BEL large corpus:
CEBPA
→
TNF
(increases, TNF Activity)
Evidence: Modified assertion
Text-mined interactions from Literome
Alaaeddine et al., Arthritis Rheum 1999
(Osteoarthritis) :
IL-4 and IL-13 decreased the
TNFa induced
C/EBP accumulation in a dose dependent manner, while IL-10 up-regulated its basal level
Granger et al., Biochim Biophys Acta 2000
(Kidney Diseases) :
Both cell-type- and stimulus-specific regulation of C/EBP mRNA expression and DNA binding activity were identified, with
C/EBPalpha being
induced by LPS, C/EBPbeta by LPS, IL-1,
TNF-alpha and C/EBPdelta by LPS, IL-1, IFN-gamma, TNF-alpha and PDGF
Kurebayashi et al., Endocr J 2001
:
In fully differentiated adipocytes,
TNF-alpha rapidly
induced C/EBPbeta and C/EBPdelta, whereas it downregulated the expression of
C/EBPalpha and PPARgamma
Liu et al., J Biochem Mol Toxicol 2002
:
Based on the knowledge that
TNFalpha preferentially
affects C/EBPalpha and that TGFbeta specifically controls C/EBPbeta and delta in their antiadipogenic action, we hypothesized that the major cause for the differential response of these two similar cell lines could be the insensitivity of C/EBPbeta and/or delta of F442A cells to the action of TCDD
Stephens et al., J Biol Chem 1992
:
Transcriptional
repression of the
C/EBP-alpha and GLUT4 genes in 3T3-L1 adipocytes by
tumor necrosis factor-alpha
Stephens et al., J Biol Chem 1991
:
Transcriptional
repression of the GLUT4 and
C/EBP genes in 3T3-L1 adipocytes by
tumor necrosis factor-alpha
Hau et al., Am J Pathol 2013
(Psoriasis) :
Visfatin and/or
TNF-a enhanced
C/EBP transcriptional activity and C/EBPa phosphorylation, which were suppressed by p38 mitogen activated protein kinase ( MAPK ) inhibition
Ohsumi et al., Endocrinology 1994
:
Treatment of 3T3-L1 cells with troglitazone ( 1-10 microM ) partially prevented this inhibitory effect of TNF on adipogenesis, and enhanced expression of
C/EBP alpha and GLUT4, even in the
presence of
TNF
Lee et al., J Neuroimmunol 1998
:
We determined that binding sites for both NF-kappaB ( -186 bp region ) and
C/EBP ( -198 bp region ) are
involved in
TNF-alpha and IL-1beta mediated ICAM-1 upregulation